{"transactions":[{"id":947271,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":70049,"kind":"person","name":"Olsson Shawn","position":1,"cik":"0002015796","reported_name":"Olsson Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-01-06T16:22:01.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2024 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the RSUs subject to the award shall vest on the one (1) year anniversary of the RSU Grant Date, and one eighth (1/8th) of the RSUs subject to the award shall vest every six (6) months thereafter on the same day of the month as the RSU Grant Date (and if there is no corresponding day, on the last day of the month). \"RSU Grant Date\" shall mean January 2, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2024 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the RSUs subject to the award shall vest on the one (1) year anniversary of the RSU Grant Date, and one eighth (1/8th) of the RSUs subject to the award shall vest every six (6) months thereafter on the same day of the month as the RSU Grant Date (and if there is no corresponding day, on the last day of the month). \"RSU Grant Date\" shall mean January 2, 2026."}],"balance_after":14000,"derivative":{"underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0002015796-26-000002","document":"wk-form4_1767734519.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2015796/000201579626000002/wk-form4_1767734519.xml","form_type":"4"}},{"id":947270,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":70049,"kind":"person","name":"Olsson Shawn","position":1,"cik":"0002015796","reported_name":"Olsson Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T16:22:01.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":84200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2024 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean January 2, 2026."}],"balance_after":84200,"derivative":{"exercise_price":16,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":84200},"source":{"system":"sec-edgar","filing":"0002015796-26-000002","document":"wk-form4_1767734519.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2015796/000201579626000002/wk-form4_1767734519.xml","form_type":"4"}},{"id":994154,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":70049,"kind":"person","name":"Olsson Shawn","position":1,"cik":"0002015796","reported_name":"Olsson Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-11-19T19:02:15.000Z","date":"2025-11-17","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares issued pursuant to the LENZ Therapeutics Operations, Inc. (previously named Lenz Therapeutics, Inc.) 2020 Equity Incentive Plan (the \"2020 Plan\"). Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2020 Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean April 26, 2021."}],"balance_after":53241,"derivative":{"exercise_price":2.08,"expiration_date":"2031-08-18","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0002015796-25-000003","document":"wk-form4_1763596932.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2015796/000201579625000003/wk-form4_1763596932.xml","form_type":"4"}},{"id":994153,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":70049,"kind":"person","name":"Olsson Shawn","position":1,"cik":"0002015796","reported_name":"Olsson Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-11-19T19:02:15.000Z","date":"2025-11-17","kind":"sale","planned":true,"acquired":false,"shares":5788,"price":26.3669,"value":152611.6172,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on August 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 5,788 shares sold in the price range of $26.12 to $26.81 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":4733,"source":{"system":"sec-edgar","filing":"0002015796-25-000003","document":"wk-form4_1763596932.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2015796/000201579625000003/wk-form4_1763596932.xml","form_type":"4"}},{"id":994152,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":70049,"kind":"person","name":"Olsson Shawn","position":1,"cik":"0002015796","reported_name":"Olsson Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-11-19T19:02:15.000Z","date":"2025-11-17","kind":"sale","planned":true,"acquired":false,"shares":4212,"price":25.7385,"value":108410.562,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on August 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 4,212 shares sold in the price range of $25.12 to $26.11 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":10521,"source":{"system":"sec-edgar","filing":"0002015796-25-000003","document":"wk-form4_1763596932.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2015796/000201579625000003/wk-form4_1763596932.xml","form_type":"4"}},{"id":994151,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":70049,"kind":"person","name":"Olsson Shawn","position":1,"cik":"0002015796","reported_name":"Olsson Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-11-19T19:02:15.000Z","date":"2025-11-17","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":2.08,"value":20800.0,"ownership":{"direct":true},"balance_after":14733,"source":{"system":"sec-edgar","filing":"0002015796-25-000003","document":"wk-form4_1763596932.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2015796/000201579625000003/wk-form4_1763596932.xml","form_type":"4"}},{"id":1174823,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":70049,"kind":"person","name":"Olsson Shawn","position":1,"cik":"0002015796","reported_name":"Olsson Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-09T19:20:28.000Z","date":"2025-04-09","kind":"exercise","planned":false,"acquired":false,"shares":1400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares issued pursuant to the LENZ Therapeutics Operations, Inc. (previously named Lenz Therapeutics, Inc.) 2020 Equity Incentive Plan (the \"2020 Plan\"). Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2020 Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean April 26, 2021."}],"balance_after":63241,"derivative":{"exercise_price":2.08,"expiration_date":"2031-08-18","underlying":"Common Stock","underlying_shares":1400},"source":{"system":"sec-edgar","filing":"0001815776-25-000022","document":"wk-form4_1744240821.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2015796/000181577625000022/wk-form4_1744240821.xml","form_type":"4"}},{"id":1174822,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":70049,"kind":"person","name":"Olsson Shawn","position":1,"cik":"0002015796","reported_name":"Olsson Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-04-09T19:20:28.000Z","date":"2025-04-09","kind":"exercise","planned":false,"acquired":true,"shares":1400,"price":2.08,"value":2912.0,"ownership":{"direct":true},"balance_after":4733,"source":{"system":"sec-edgar","filing":"0001815776-25-000022","document":"wk-form4_1744240821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2015796/000181577625000022/wk-form4_1744240821.xml","form_type":"4"}},{"id":1304455,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":70049,"kind":"person","name":"Olsson Shawn","position":1,"cik":"0002015796","reported_name":"Olsson Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-13T17:26:58.000Z","date":"2025-01-09","kind":"grant","planned":false,"acquired":true,"shares":80100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2024 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean January 9, 2025."}],"balance_after":80100,"derivative":{"exercise_price":26.34,"expiration_date":"2035-01-08","underlying":"Common Stock","underlying_shares":80100},"source":{"system":"sec-edgar","filing":"0001815776-25-000009","document":"wk-form4_1736807211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2015796/000181577625000009/wk-form4_1736807211.xml","form_type":"4"}},{"id":1329308,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":70049,"kind":"person","name":"Olsson Shawn","position":1,"cik":"0002015796","reported_name":"Olsson Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-17T19:55:30.000Z","date":"2024-12-16","kind":"exercise","planned":false,"acquired":false,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares issued pursuant to the LENZ Therapeutics Operations, Inc. (previously named Lenz Therapeutics, Inc.) 2020 Equity Incentive Plan (the \"2020 Plan\"). Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2020 Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean April 26, 2021."}],"balance_after":64641,"derivative":{"exercise_price":2.08,"expiration_date":"2031-08-18","underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001815776-24-000074","document":"wk-form4_1734483323.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2015796/000181577624000074/wk-form4_1734483323.xml","form_type":"4"}},{"id":1329307,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":70049,"kind":"person","name":"Olsson Shawn","position":1,"cik":"0002015796","reported_name":"Olsson Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-12-17T19:55:30.000Z","date":"2024-12-16","kind":"exercise","planned":false,"acquired":true,"shares":3333,"price":2.08,"value":6932.64,"ownership":{"direct":true},"balance_after":3333,"source":{"system":"sec-edgar","filing":"0001815776-24-000074","document":"wk-form4_1734483323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2015796/000181577624000074/wk-form4_1734483323.xml","form_type":"4"}},{"id":1562106,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":70049,"kind":"person","name":"Olsson Shawn","position":1,"cik":"0002015796","reported_name":"Olsson Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-25T20:34:51.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2024 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean March 21, 2024."}],"balance_after":105000,"derivative":{"exercise_price":15.05,"expiration_date":"2034-03-20","underlying":"Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001815776-24-000022","document":"wk-form4_1711413279.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2015796/000181577624000022/wk-form4_1711413279.xml","form_type":"4"}},{"id":1562105,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":70049,"kind":"person","name":"Olsson Shawn","position":1,"cik":"0002015796","reported_name":"Olsson Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-25T20:34:51.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":50915,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Stock option assumed in connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 14, 2023 (the \"Merger Agreement\"), by and among the Issuer, Generate Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of the issuer, and LENZ Therapeutics Operations, Inc. (previously named Lenz Therapeutics, Inc.), a Delaware corporation (\"LENZ OpCo\"), in exchange of an outstanding option to purchase shares of LENZ OpCo, pursuant to the terms and conditions of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the LENZ Therapeutics Operations, Inc. (previously named Lenz Therapeutics, Inc.) 2020 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean March 6, 2023."}],"balance_after":50915,"derivative":{"exercise_price":6.04,"expiration_date":"2033-06-19","underlying":"Common Stock","underlying_shares":50915},"source":{"system":"sec-edgar","filing":"0001815776-24-000022","document":"wk-form4_1711413279.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2015796/000181577624000022/wk-form4_1711413279.xml","form_type":"4"}},{"id":1562104,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":70049,"kind":"person","name":"Olsson Shawn","position":1,"cik":"0002015796","reported_name":"Olsson Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-25T20:34:51.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":30466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Stock option assumed in connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 14, 2023 (the \"Merger Agreement\"), by and among the Issuer, Generate Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of the issuer, and LENZ Therapeutics Operations, Inc. (previously named Lenz Therapeutics, Inc.), a Delaware corporation (\"LENZ OpCo\"), in exchange of an outstanding option to purchase shares of LENZ OpCo, pursuant to the terms and conditions of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the LENZ Therapeutics Operations, Inc. (previously named Lenz Therapeutics, Inc.) 2020 Equity Incentive Plan)  through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean April 26, 2021."}],"balance_after":30466,"derivative":{"exercise_price":5.05,"expiration_date":"2032-11-23","underlying":"Common Stock","underlying_shares":30466},"source":{"system":"sec-edgar","filing":"0001815776-24-000022","document":"wk-form4_1711413279.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2015796/000181577624000022/wk-form4_1711413279.xml","form_type":"4"}},{"id":1562103,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":70049,"kind":"person","name":"Olsson Shawn","position":1,"cik":"0002015796","reported_name":"Olsson Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-25T20:34:51.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":67974,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Stock option assumed in connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 14, 2023 (the \"Merger Agreement\"), by and among the Issuer, Generate Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of the issuer, and LENZ Therapeutics Operations, Inc. (previously named Lenz Therapeutics, Inc.), a Delaware corporation (\"LENZ OpCo\"), in exchange of an outstanding option to purchase shares of LENZ OpCo, pursuant to the terms and conditions of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the LENZ Therapeutics Operations, Inc. (previously named Lenz Therapeutics, Inc.) 2020 Equity Incentive Plan)  through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean April 26, 2021."}],"balance_after":67974,"derivative":{"exercise_price":2.08,"expiration_date":"2031-08-18","underlying":"Common Stock","underlying_shares":67974},"source":{"system":"sec-edgar","filing":"0001815776-24-000022","document":"wk-form4_1711413279.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2015796/000181577624000022/wk-form4_1711413279.xml","form_type":"4"}}]}